Dr. Eric Omori Omwenga

C.O.D, Microbiology & Parasitology

Biography

Dr. rer. nat. Omwenga Eric Omori.

Senior Lecturer & Chair, Department of Medical Microbiology & Parasitology, School of Health Sciences Kisii University | Adjunct Research Scientist, AICAD | 📧 omorieric@kisiiuniversity.ac.ke | 📞 +254 725 806875 +254 735 927 832.   | ORCID: 0000-0001-8583-8109 | https://www.researchgate.net/profile/Eric_Omwenga/research |Google scholar:  https://scholar.google.com/citations?user=VG1ZL6kAAAAJ&hl=en | H-index: 12; i10-index: 14.

 

Dr. Eric Omori Omwenga is a biomedical scientist and Registered Medical Laboratory Technologist (Registration No. A016479) specializing in Medical Microbiology, with expertise in antimicrobial resistance (AMR), microbial pathogenesis and virulence, molecular microbiology, and nanobiotechnology. He holds a PhD in Natural Sciences (Microbiology/Nanobiotechnology) from Westfälische Wilhelms-Universität Münster, Germany (Magna Cum Laude), where his doctoral research pioneered the application of biopolymer-based nanoencapsulation of select flavonoid phytochemicals (Baicalein and Quercetin) to inhibit bacterial quorum sensing, biofilm formation, and virulence in multidrug-resistant pathogens using bioengineered Escherichia coli Top10 biosensor systems. His work demonstrated how nanotechnology can enhance the bioavailability, stability, and targeted delivery of antimicrobial compounds while reducing toxicity, thereby advancing innovative approaches to combat antimicrobial resistance.

Dr. Omwenga has extensive experience in university teaching of over 15 years, postgraduate supervision, curriculum development, research project management, grant management, and community engagement. He serves as a member of the Kisii Teaching and Referral Hospital Institutional Scientific and Ethics Review Committee ISERC), where he has contributed immensely on ethical review and oversight of scientific research. Also, he is an Adjunct Researcher at the African Institute for Capacity Development (AICAD), contributing to multidisciplinary research, innovation, and regional development.

Dr. Omwenga's research interests integrate One Health principles with advanced molecular and nanobiotechnological approaches to address the growing global threat of AMR. His work focuses on antimicrobial discovery, phage therapy, antivirulence strategies, microbial quorum sensing & quenching, biofilm formation & disruption, microbial resistance gene surveillance, infectious diseases and nanoparticle-based drug delivery systems. Through this multidisciplinary approach, he seeks to develop scalable and cost-effective interventions that improve disease prevention, diagnostics, and therapeutics, particularly in low- and middle-income countries where the burden of infectious diseases and AMR remains high. His research excellence has attracted more than USD 800,000 in competitive research funding and laboratory infrastructure support from prestigious organizations, including the Canadian Institutes of Health Research (CIHR), the African Development Bank (AfDB), Seeding Labs, DAAD, UNESCO-TWAS, and other international funding agencies. He has served as both Principal Investigator and Co-Investigator on multidisciplinary projects addressing pandemic vaccine preparedness, antimicrobial resistance surveillance, aquaculture health, One Health, and sustainable water, sanitation, and hygiene (WASH) systems.

Dr. Omwenga has authored and co-authored over 50 peer-reviewed publications in leading international journals, including PLoS ONE, BMJ OpenEthnopharmacology, Colloids and Surfaces B: Bio interfaces and Canadian Journal of Infectious Diseases and Medical Microbiology. His research has significantly advanced knowledge in biofilm inhibition, quorum sensing & quenching, antimicrobial resistance profiling, molecular diagnostics, and community-based AMR mitigation strategies. He is an active member of several professional organizations, including the American Society for Microbiology (ASM), the Microbiology Society (UK), the International Society for Infectious Diseases (ISID), the Bioethics Society of Kenya, KMLTTB and the DAAD Alumni Association. He is also a reviewer of various medical microbiology journals among them being Malaysian Journal of Microbiology, African Journal for Science, Technology and Social Sciences, African Journal of Pure and Applied sciences amongst others. 

Dr. Omwenga continues to provide leadership in research, postgraduate mentorship, competitive grant acquisition, and international collaboration, contributing to scientific capacity building, innovation, and improved public health and health security in Africa and beyond.

 

Research Interests

ANTIMICROBIAL RESISTANCE (AMR) ONE HEALTH ETHNOPHARMACOLOGY & DRUG DISCOVERY BACTERIAL QUORUM SENSING AND QUENCHING STRATEGIES MICROBIAL GENOMICS AND METAGENOMICS VACCINOLOGY CANCER RESEARCH

Education Background

NYAMBARIA HIGH SCHOOL
1996 - 1999
MASENO UNIVERSITY, KENYA
2000 Sep - 2005 Dec
Bachelors
KENYATTA UNIVERSITY, KENYA
2006 Sep - 2009 Dec
Masters
MASENO UNIVERSITY, KENYA
2004 Sep - 2012 Dec
Bachelors
Westfälische Wilhelms-Universität Münster, WWU, GERMANY
2014 April - 2017 April
Doctor of Pholosophy(PhD)

Work Experience

KISII UNIVERISTY
Nov 2014 - 2023
KISII UNIVERSITY
March 2023 -
KISII UNIVERSITY
Nov 2010 - 2014

Publications

No publications available.

Research Grants

KONSERVE -AB project - Pilot study on Antibiotics resistance7000 euros
PI: |
KES
SEEDING LABS
PI: Dr. ERIC OMORI OMWENGA | SEEDING LABS
KES
On Strengthening Pandemic Vaccine Preparedness in Africa (SPAVPA) 2.0: Lessons from African countries with high and low Covid 19 vaccination rates.
PI: Obidimma, Ezekiel (PI) | Canadian Institutes for Health Research
KES
Advancing Research on Sustainable Water, Sanitation and Hygiene Solutions”
PI: Prof. Dr. Sarah Beck | University of British Colombia, Canada - seeding grant
KES
Strengthening Pandemic Vaccine Preparedness in Africa (SPAVPA): Lessons from African countries with high and low COVID­19 vaccination rates
PI: Ezezika, Obidimma | Canadian institutes of Health Research
KES
HEST 2 grant
PI: Prof. Dr. Nathan Ogechi | Dr. ERIC OMORI OMWENGA
KES
ONE HEALTH APPROACH IN UNRAVELLING RESISTOMES TRANSMISSION & POSSIBLE BACTERIOPHAGE USAGE ON EXTENDED SPECTRUM BETA-LACTAMASE & CARBAPENEM RESISTANT ENTEROBACTERIACEAE ON AQUACULTURE PRACTICES IN THE KISII COUNTY, KENYA
PI: Dr. ERIC OMORI OMWENGA | KISII UNIVERSITY - INTERNAL GRANT
KES

Skills

AMR, Quorum sensing, Natural products, Molecular biology/techniques, Mammalian cell culturing, ONE HEALTH & other microbial and laboratory diagnostic techniques Grant proposal writing; Grant management; Statistical data analysis; Scientific writing and publication; International collaborations; community engagement & outreach; Capacity building & Training; Extension services